(WBNG) -- The FDA made headlines earlier this week announcing the approval of a new drug aimed to treat Alzheimer's Disease.
The announcement marks the first time in more than 20 years that the FDA has approved a new treatment for Alzheimer's.
The way the drug works is by removing the buildup of toxic proteins from the brain. Scientists believe these proteins to be a key factor in the disease occurring.
Central New York Alzheimer's Association Chapter Executive Cathy James made it clear that getting the drug approved by the FDA was only the first step in its, hopefully, future success.
"Access to this treatment is the next priority of the Alzheimer's Association. We want to make sure that everyone who is eligible to take this medication has access to it," says James.
She says it may be a lengthy process in terms of rolling out the prescription, but the manufacturing of the medications is slated to begin soon.
James also made it clear that although this new drug is not a "magic pill" and that it might not be approved for everyone suffering from the disease, it may very well be the first step in a much brighter future of treatment.